{"disease":{"id":"advanced-solid-tumors-with-her2-abnormalities","name":"advanced solid tumors with her2 abnormalities"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03410927","title":"A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":19,"lead_sponsor_name":"Taiho Oncology, Inc.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}